Exercise Extends Lifespan by Boosting a Key Cholesterol Enzyme in Aging Hearts

Cardiovascular disease is the leading cause of death globally, and its incidence rises sharply with age. Understanding exactly why the aging heart deteriorates — and how lifestyle interventions like exercise counteract that deterioration — is a central challenge in longevity research.

This study focused on HMGCR (3-Hydroxy-3-methylglutaryl coenzyme A reductase), best known as the molecular target of statin drugs. HMGCR catalyzes the conversion of HMG-CoA to mevalonate, the rate-limiting step in cholesterol biosynthesis. Beyond its metabolic role, prior work suggested Hmgcr influences germ cell migration and heart development, hinting at broader biological functions.

Using Drosophila melanogaster as an aging model, the researchers found that Hmgcr expression fell significantly in cardiac tissue as flies aged, correlating with measurable impairment in cardiac function. When they selectively upregulated Hmgcr specifically in heart tissue, aging-associated cardiac dysfunction was substantially reversed and fly lifespan was extended. This establishes a causal, not merely correlative, relationship between cardiac Hmgcr levels and heart aging.

Most translationally compelling is the exercise finding: physical exercise in aging flies upregulated Hmgcr expression in cardiac tissue, producing cardiac functional improvements and lifespan extension comparable to direct genetic upregulation. This positions Hmgcr as a key molecular mediator of exercise's cardioprotective effects during aging.

Caveats are meaningful. The study relies entirely on Drosophila, which, while a validated aging model, differs substantially from mammalian cardiac physiology. HMGCR is also the target of widely prescribed statins, which inhibit the enzyme — raising important questions about whether statin use could blunt some of exercise's cardioprotective benefits in older adults. Human validation studies are needed before clinical conclusions can be drawn.